Abstract
The association of cancer with low serum total cholesterol is well established. Less clear is the relationship of cancer with the cholesterol distribution among the different lipoprotein classes. Conflicting results have been reported on low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and serum triglyceride levels in different types of tumor. Total serum cholesterol, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, and serum triglycerides were analyzed in 530 patients with newly diagnosed cancer (97 with hematological malignancies, 92 with tumor of the lung, 108 of the upper digestive system, 103 of colon, 32 of breast, and 98 of the genitourinary system) and in 415 non-cancer subjects. Anthropometric (body mass index) and biochemical (serum albumin) indices of nutritional status were also determined in all subjects. Total cholesterol, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, serum albumin, and body mass index were significantly lower in cancer than in non cancer-subjects. The lowest values of total cholesterol, low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol were recorded in patients with hematological malignancies and the highest in patients with breast tumor. All the cancer groups, with the exception of women with breast cancer, showed significantly lower total cholesterol, low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol than age- and sex-matched non-cancer subjects. Multiple regression analysis with low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, and triglycerides as dependent variables and sex, age, body mass index, albumin, and cancer (dummy variable) as independent variables, showed that cancer was independently associated with low levels of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol and with high values of serum triglycerides. Total cholesterol, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, serum triglycerides, body mass index and serum albumin were significantly lower in patients with metastatic than in patients with non-metastatic solid tumor. The significant difference in low-density lipoprotein-cholesterol and serum triglycerides between patients with metastatic and non-metastatic cancer was lost when lipoprotein cholesterol and serum triglyceride levels were adjusted for nutritional variables. The lipid profile in cancer patients is characterized by low low-density lipoprotein-cholesterol, low high-density lipoprotein-cholesterol and relatively high serum triglycerides. The abnormality is a common feature of both hematological and solid tumors and is not entirely explained by poor nutrition.
Similar content being viewed by others
References
Epstein FH. Low serum cholesterol, cancer and other noncardiovascular disorders. Atherosclerosis 1992; 94:1.
Kritchewsky SB, Kritchewsky D. Serum cholesterol and cancer risk: an epidemiologic prespective. Annu Rev Nutr 1992; 12:391.
Kritz H, Zielinski C, Sinzinger H. Low cholesterol and cancer. J Clin Oncol 1996; 14:3043.
Sommariva D, Branchi A, Tirrito M, Bonfiglioli D, Pini C, Scandiani L, Ottomano C, Fasoli A. Relationship of serum triglyceride concentration to lipoprotein composition and concentration in normolipidemic and hyperlipidemic subjects. Res Clin Lab 1988; 18:281.
Alexopoulos CG, Blatsios B, Avgerinos A. Serum lipids and lipoprotein disorders in cancer patients. Cancer 1987; 60:3065.
Umeki S. Decreases in serum cholesterol levels in advanced lung cancer. Respiration 1993; 60:178.
Borrelli R, Sordo G del, De Filippo E, Contaldo F, Parisi V, Beneduce G. High serum HDL-cholesterol in pre- and post-menopausal women with breast cancer in southern Italy. Adv Exp Med Biol 1993; 348:149.
Dessì S, Batetta B, Pulisci D, Spano O, Tessitore L, Costelli P, Baccino FM, Aroasio E, Pani P. Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 1994; 73:253.
Lane DM, Boatman KK, McConathy WJ. Serum lipids and apolipoproteins in women with breast masses. Breast Cancer Res Treat 1995; 34:161.
Goodwin PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A, Redwood S, Hood N, Del Giudice E, Sidlofsky S, McCready D, Wilkinson R, Mahoney L, Connelly P, Page DL. Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer 1997; 27:284.
Halton JM, Nazir DJ, McQueen MJ, Barr RD. Blood lipid profiles in children with acute lymphoblastic leukemia. Cancer 1998; 83:379.
Schreier LE, Berg GA, Basilio FM, Lopez GI, Etkin AE, Wikinski RL. Lipoprotein alterations, abdominal fat distribution and breast cancer. Biochem Mol Biol Int 1999; 47:681.
Gilbert HS, Ginsberg H, Fagerstrom R, Brown WV. Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity. Am J Med 1981; 71:595.
Knapp ML, Al-Sheibani S, Riches PG. Alterations of serum lipids in breast cancer: effects of disease activity, treatment, and hormonal factors. Clin Chem 1991; 37:2093.
Henriksson P, Eriksson M, Ericsson S, Rudling M, Stege R, Berglund L, Angelin B. Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet 1989; II:1178.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499.
Reverter JC, Sierra J, Marti-Tutusaus JM, Montserrat E, Granena A, Rozman C. Hypocholesterolemia in acute myelogenous leukemia. Eur J Haematol 1988; 41:317.
Vitols S, Gahrton G, Bjorkholm M, Peterson C. Hypocholesterolemia in malignancy due to elevated low-density-lipoprotein receptor activity in tumor cells: evidence from patients with leukaemia. Lancet 1985; II:1150.
Blackman JD, Cabana VG, Mazzone T. The acute phase response and associated lipoprotein abnormalities accompanying lymphoma. J Intern Med 1993; 233:201.
Munker R, Cremer P, Fries S, Hiller E. Serum lipids in patients with Hodgkin’s disease in complete remission. Acta Oncol 1997; 36:75.
Baroni S, Scribano D, Pagano L, Zuppi C, Leone G, Giardina B. Lipids and lipoproteins in acute lymphoblastic leukemia. Leuk Res 1994; 18:643.
Alexopoulos CG, Pournaras S, Vaslamatzis M, Avgerinos A, Raptis S. Changes in serum lipids and lipoproteins in cancer patients during chemotherapy. Cancer Chemother Pharmacol 1992; 30:412.
Goldstein JL, Brown MS. The low density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1997; 46:897.
Ettinger WH, Harris T. Causes of hypocholesterolemia. Coron Artery Dis 1993; 4:854.
Flaim E, Williford WO, Mullen JL, Buzby GP, Crosby LO. The relationship of serum cholesterol and vitamin A in hospitalized patients with and without cancer. Am J Clin Nutr 1986; 44:370.
Fiorenza AM, Branchi A, Cardena’ A, Molgora M, Rovellini A, Sommariva D. Serum cholesterol levels in patients with cancer. Relationship with nutritional status. Int J Clin Lab Res 1996; 26:37.
Kris-Etherton PM, Krummel D, Russel ME, Dreon D, Mackey S, Borchers J, Wood PD. The effect of diet on plasma lipids, lipoproteins and coronary heart disease. J Am Diet Assoc 1988; 88:1373.
Blackett PR, Koren E, Blackstock R, Downs D, Wang CS. Hyperlipidemia in acute lymphoblastic leukemia. Ann Clin Lab Sci 1984; 14:123.
Favrot MC, Dellamonica C, Souillet G. Study of blood lipids in 30 children with a malignant hematological disease or carcinoma. Biomed Pharmacother 1984; 35:55.
Cabana VG, Siegel JN, Sabesin SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989; 30:39.
Hardardottir I, Grunfeld C, Feingold KR. Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 1994; 5:207.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fiorenza, A.M., Branchi, A. & Sommariva, D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 30, 141–145 (2000). https://doi.org/10.1007/s005990070013
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s005990070013